APA

van den Bemt B. J. F., Vos K., den Broeder A. A., Blom M., Thurlings R. M., Bartelds G. M., Stapel S. O., Barrera P., Tak P. P., Nurmohamed M. T. & Wolbink G. (20090903). A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. : Annals of the rheumatic diseases.

Chicago

van den Bemt B J F, Vos K, den Broeder A A, Blom M, Thurlings R M, Bartelds G M, Stapel S O, Barrera P, Tak P P, Nurmohamed M T and Wolbink G-J. 20090903. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. : Annals of the rheumatic diseases.

Harvard

van den Bemt B. J. F., Vos K., den Broeder A. A., Blom M., Thurlings R. M., Bartelds G. M., Stapel S. O., Barrera P., Tak P. P., Nurmohamed M. T. and Wolbink G. (20090903). A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. : Annals of the rheumatic diseases.

MLA

van den Bemt B J F, Vos K, den Broeder A A, Blom M, Thurlings R M, Bartelds G M, Stapel S O, Barrera P, Tak P P, Nurmohamed M T and Wolbink G-J. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. : Annals of the rheumatic diseases. 20090903.